Form 4: Bio-Key International Executive Acquires Shares Under Employee Stock Purchase Plan

James David Sullivan, Chief Legal Officer, SVP Strategy & Compliance at Bio-Key International, acquired 139 shares of common stock under the company's Employee Stock Purchase Plan on December 31, 2024.

Summary

• On December 31, 2024, James David Sullivan, Chief Legal Officer, SVP Strategy & Compliance at Bio-Key International, acquired 139 shares of common stock.
• The acquisition was made under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan.
• The price per share was $1.4.
• Following the transaction, Sullivan directly owns 44,712 shares of Bio-Key International.
• All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.
• Holdings do not include options to purchase 348 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction by an executive under an employee stock purchase plan. It doesn't indicate any significant positive or negative outlook for the company.

Positives

• An executive's participation in the Employee Stock Purchase Plan can be seen as a positive sign of confidence in the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it shows confidence from a company executive.

Key Dates

Keywords

BIO-key International, James David Sullivan, Employee Stock Purchase Plan, BKYI, share acquisition, Form 4, reverse stock split, executive, ownership